NIH scientists use artificial intelligence to improve next-generation imaging of cells in the back of the eye
What AI is doing faster:
Automated image analysis
AI can instantly identify signs of diseases like diabetic retinopathy, glaucoma, or age-related macular degeneration, which would otherwise require a specialist to analyze.
Segmentation and labeling
AI can rapidly segment retinal layers or highlight lesions, a task that would take clinicians several minutes per image.
Triage and prioritization
AI can help flag urgent cases in massive datasets almost instantly.
Reporting
Automatically generates diagnostic reports.
⚙️ Compared to:
- Manual review by ophthalmologists or trained technicians, which can take 5–10 minutes per image depending on complexity, AI can often perform similar tasks in under a second—leading to the “100x faster” claim.
🔬 Real-world impact
- Faster screenings in large-scale eye care programs.
- Early detection in underserved or rural areas using portable devices plus AI.
- Reduced workload on human experts.
⚕️ Clinical Implications
Early Detection
Improved imaging can facilitate the early diagnosis of retinal diseases like AMD, potentially leading to better patient outcomes.
Increased Accessibility
Faster imaging processes can make advanced retinal diagnostics more accessible, especially in underserved or rural areas.
Reduced Clinician Workload
Automation of image processing can alleviate the burden on ophthalmologists, allowing them to focus more on patient care.
